In utero Exposure to β-2-Adrenergic Receptor Agonist Drugs and Risk for Autism Spectrum Disorders

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pediatrics

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1542/peds.2015-1316PMID 26738885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Utero Exposure to Selective Serotonin Reuptake Inhibitors and Risk for Autism Spectrum Disorder

  2014cited by this paper
• Maternal Immune-Mediated Conditions, Autism Spectrum Disorders, and Developmental Delay

  2013cited by this paper
• Drug utilization and asthma control among young Danish adults with asthma – analyses of trends and determinants

  2012cited by this paper
• β-Adrenergic receptor subtype signaling in heart: From bench to bedside

  2012cited by this paper
• Does treatment of premature labor with terbutaline increase the risk of autism spectrum disorders?

  2011cited by this paper
• The Danish Civil Registration System

  2011cited by this paper
• Nationwide register‐based surveillance system on drugs and pregnancy in Finland 1996–2006

  2011cited by this paper
• Prenatal exposure to β2-adrenergic receptor agonists and risk of autism spectrum disorders

  2011cited by this paper
• Does treatment of premature labor with terbutaline increase the risk of autism spectrum disorders?

  2011cited by this paper
• Validity of Childhood Autism in the Danish Psychiatric Central Register: Findings from a Cohort Sample Born 1990–1999

  2010cited by this paper
• Sex differences in the evaluation and diagnosis of autism spectrum disorders among children.

  2010cited by this paper
• Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders

  2010cited by this paper
• Autism spectrum disorders, maternal characteristics and obstetric complications among singletons born in Alberta, Canada.

  2010cited by this paper
• The Impact of Exposure Misclassification on Associations Between Prepregnancy BMI and Adverse Pregnancy Outcomes

  2010cited by this paper
• Socioeconomic Inequality in the Prevalence of Autism Spectrum Disorder: Evidence from a U.S. Cross-Sectional Study

  2010cited by this paper
• Effect of β2-Adrenergic Receptor Polymorphism in Asthma Control of Patients Receiving Combination Treatment

  2009cited by this paper
• Association of Family History of Autoimmune Diseases and Autism Spectrum Disorders

  2009cited by this paper
• In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes.

  2009cited by this paper
• Birth Weight and Gestational Age Characteristics of Children With Autism, Including a Comparison With Other Developmental Disabilities

  2008cited by this paper
• Acute Tocolysis for Uterine Activity Reduction in Term Labor: A Review

  2008cited by this paper
• Prenatal environmental exposures and child health: Minnesota's role in the National Children's Study.

  2008cited by this paper
• Effect of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: a UK population-based study

  2008cited by this paper
• Parental Psychiatric Disorders Associated With Autism Spectrum Disorders in the Offspring

  2008cited by this paper
• Asthma control during pregnancy and the risk of preterm delivery or impaired fetal growth.

  2008cited by this paper
• Autism Spectrum Disorders in Relation to Distribution of Hazardous Air Pollutants in the San Francisco Bay Area

  2006cited by this paper
• Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status.

  2005cited by this paper
• β-Agonist Tocolytic Therapy

  2005cited by this paper
• Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study.

  2005cited by this paper
• beta-Agonist tocolytic therapy.

  2005cited by this paper
• β 2-Adrenergic Receptor Activation and Genetic Polymorphisms in Autism: Data from Dizygotic Twins

  2005cited by this paper
• Terbutaline Is a Developmental Neurotoxicant: Effects on Neuroproteins and Morphology in Cerebellum, Hippocampus, and Somatosensory Cortex

  2004cited by this paper
• Normal pregnancy outcomes in a population-based study including 2,968 pregnant women exposed to budesonide.

  2003cited by this paper
• Autism and Möbius sequence: an exploratory study of children in northeastern Brazil.

  2003cited by this paper
• Developmental toxicity of terbutaline: critical periods for sex-selective effects on macromolecules and DNA synthesis in rat brain, heart, and liver.

  2003cited by this paper
• Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies.

  2003cited by this paper
• Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth

  2002cited by this paper
• A heuristic approach to the formulas for population attributable fraction

  2001cited by this paper
• A Population-Based Prescription Study of Asthma Drugs during Pregnancy: Changing the Intensity of Asthma Therapy and Perinatal Outcomes

  2001cited by this paper
• Beta-adrenoceptor signaling in the developing brain: sensitization or desensitization in response to terbutaline.

  2001cited by this paper
• Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.

  2000cited by this paper
• The Danish Psychiatric Central Register.

  1997cited by this paper
• Fetal atrial flutter associated with maternal beta-sympathomimetic drug exposure.

  1997cited by this paper
• Severity of asthma and perinatal outcome

  1993cited by this paper
• Prenatal terbutaline exposure in the rat: selective effects on development of noradrenergic projections to cerebellum.

  1989cited by this paper
• Transfer of terbutaline across the human placenta in late pregnancy.

  1985cited by this paper
• Fenoterol: A Beta2‐adrenergic Agonist for Use in Asthma; Pharmacology, Pharmacokinetics, Clinical Efficacy and Adverse Effects

  1985cited by this paper
• Transfer of Salbutamol in the human placenta in vitro.

  1981cited by this paper

• Prenatal exposure to maternal asthma and asthma medication and neurodevelopmental outcomes: a population cohort study of 179,024 children.

  2026cites this paper
• The Association Between Maternal Asthma and Child Autism: A Systematic Review and Meta‐Analysis

  2025influential citation
• Vitamin C and Gallic Acid Ameliorate Motor Dysfunction, Cognitive Deficits, and Brain Oxidative Stress in a Valproic Acid‐Induced Model of Autism

  2025cites this paper
• Environmental Risk Factors in Autism Spectrum Disorder: A Narrative Review.

  2024cites this paper
• A case–control study on pre-, peri-, and neonatal risk factors associated with autism spectrum disorder among Armenian children

  2024cites this paper
• Roles of Epigenetics and Glial Cells in Drug-Induced Autism Spectrum Disorder

  2024cites this paper
• Autism Spectrum Disorders-A Review on The Preventive Aspects

  2023cites this paper
• Neurodevelopmental Outcomes Among Offspring Exposed to Corticosteroid and B2-Adrenergic Agonists In Utero

  2023cites this paper
• Maternal atopic conditions and autism spectrum disorder: a systematic review

  2023cites this paper
• Antipsychotic Drugs in Autistic Children using LC/MS-MS: Better-Fixed Doses Necessary for the Middle East

  2023cites this paper
• Contributions of epigenetic inheritance to the predisposition of major psychiatric disorders: theoretical framework, evidence, and implications.

  2022cites this paper
• Towards the convergent therapeutic potential of G protein‐coupled receptors in autism spectrum disorders

  2022cites this paper
• Prevention in Autism Spectrum Disorder: A Lifelong Focused Approach

  2021cites this paper
• Zinc and Copper Brain Levels and Expression of Neurotransmitter Receptors in Two Rat ASD Models

  2021cites this paper
• In utero exposure to ritodrine during pregnancy and risk of autism in their offspring until 8 years of age

  2021cites this paper
• Maternal Prenatal Exposures in Pregnancy and Autism Spectrum Disorder: An Insight into the Epigenetics of Drugs and Diet as Key Environmental Influences.

  2020cites this paper
• T cell populations in children with autism spectrum disorder and co-morbid gastrointestinal symptoms.

  2020cites this paper
• The Effect of Asthma Severity on Perinatal Outcomes: A Tertiary Hospital Experience

  2020cites this paper
• Complete antigen-bridged DNA strand displacement amplification immuno-PCR assay for ultrasensitive detection of salbutamol.

  2020cites this paper
• Evaluation of Prenatal and Perinatal Features in Children Diagnosed with Autism Spectrum Disorder: Is There a Gender Difference?

  2020cites this paper
• Parental asthma and risk of autism spectrum disorder in offspring: A population and family‐based case‐control study

  2019cites this paper
• Autism spectrum disorders: let’s talk about glucose?

  2019cites this paper
• Pharmacology and Therapeutics of Bronchodilators Revisited

  2019cites this paper
• Fármacos tocolíticos

  2019cites this paper
• Autism Spectrum Disorders and Perinatal Complications—Is Oxidative Stress the Connection?

  2019cites this paper
• Trauma and Autism Spectrum Disorder: Review, Proposed Treatment Adaptations and Future Directions

  2019cites this paper
• Autism Spectrum Disorder and Prenatal Risk Factors

  2019cites this paper
• Family history of immune conditions and autism spectrum and developmental disorders: Findings from the study to explore early development

  2018cites this paper
• Médicaments tocolytiques

  2018cites this paper
• Prenatal, perinatal, and neonatal risk factors of autism spectrum disorder

  2018cites this paper
• In utero beta‐2‐adrenergic agonists exposure and risk of epilepsy: A Danish nationwide population‐based cohort study

  2018cites this paper
• Risk of childhood cerebral palsy following prenatal exposure to ß2-adrenergic receptor agonist: A nationwide cohort study

  2018cites this paper
• The Changing Epidemiology of Autism Spectrum Disorders.

  2017cites this paper
• Association Between Maternal Use of SSRI Medications and Autism in Their Children.

  2017cites this paper
• In utero exposure to β-2-adrenergic receptor agonist and attention-deficit/hyperactivity disorder in children

  2017cites this paper
• Resveratrol protects from lipopolysaccharide-induced inflammation in the uterus and prevents experimental preterm birth

  2017cites this paper
• Position Article on Integrating Data and Model to Understand Disease Interactions

  2017cites this paper
• Association between Beta-Sympathomimetic Tocolysis and Risk of Autistic Spectrum Disorders, Behavioural and Developmental Outcome in Toddlers

  2017cites this paper
• Beta‐2 receptor agonist exposure in the uterus associated with subsequent risk of childhood asthma

  2017cites this paper
• Challenges in Formulating Explanatory Models for Comorbidities

  2016cites this paper
• [Tocolysis for preterm labor without premature preterm rupture of membranes].

  2016cites this paper
• Autism Spectrum Disorder and Chiari 1 Malformation Co-occurring in a Child.

  2016cites this paper
• The Complex Etiology of Autism Presents Challenges in Risk Communication

  2016cites this paper
• Genetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD)

  2016cites this paper